1992
DOI: 10.1136/jcp.45.10.860
|View full text |Cite
|
Sign up to set email alerts
|

Monoclonal antibody JC1: new reagent for studying cell proliferation.

Abstract: Aim: To characterise a newly developed mouse monoclonal antibody JC1 which recognises a nuclear antigen present in proliferating cells in normal tissues and neoplastic lesions, and which is absent in resting cells. Methods: The methodology was established using a representative range of frozen sections from normal tissues and from certain tumours which were immunostained with antibodies Ki67 and JC1. The molecular weight of the antigen recognised by JC1 was obtained by western blot analysis and this was compar… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
10
0
4

Year Published

1994
1994
2010
2010

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 18 publications
(14 citation statements)
references
References 25 publications
0
10
0
4
Order By: Relevance
“…[26][27][28][29][30][31][32][33]. The two proteins that have arguably found the most application to the study of human tumors are the Ki-67 antigen and PCNA (11,34).…”
Section: Discussionmentioning
confidence: 99%
“…[26][27][28][29][30][31][32][33]. The two proteins that have arguably found the most application to the study of human tumors are the Ki-67 antigen and PCNA (11,34).…”
Section: Discussionmentioning
confidence: 99%
“…The constant increase in the incidence of these cancers in both sexes in recent years makes the knowledge of tumor types and identification of new prognosticators important. Histopathological characterization differs from other tumors and contradictory observations on the prognostic role of Ki-67 proliferative activity were reported [18][19][20][21][22][23][24].…”
Section: Discussionmentioning
confidence: 98%
“…Ki67 expression is highly present in a great number of tumor cells before any treatment [18,21,22]. In this assay, HPI of Ki67 was expressed in 9.67% of the tumors of the NG and in 33.33% of the tumors of the AG (p=0.052).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…More recently, there have been new monoclonal antibodies generated to as-yet undefined nuclear antigens associated with cell proliferation, and which await further characterization: JC1 [18], which identifies 123 and 212 kd protein, and KiS1, which identifies a 160 kd protein [32].…”
mentioning
confidence: 99%